A man’s complaint that Invest NI failed to provide his company with adequate guidance and support during its application for a Research and Development Grant has not been upheld.
The Ombudsman has found that a care home provided a patient with the right level of the drug Quetiapine, and addressed a complainant’s concerns about the diet the patient received in the home.